Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Phillip, Parente"'
Publikováno v:
Urology Case Reports, Vol 55, Iss , Pp 102768- (2024)
We describe a unique presentation of acute lower limb ischaemia due to metastatic seminoma in a middle-aged man with a large retroperitoneal mass. The patient underwent vascular bypass surgery of the right lower limb, completed chemotherapy, and had
Externí odkaz:
https://doaj.org/article/2f169723bbe342e49b17cddd3900d748
Autor:
Angelyn Anton, Sruti Pillai, Marie Christine Semira, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun Azad, Edmond M. Kwan, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Olivia Baenziger, Peter Gibbs, Ben Tran
Publikováno v:
BJUI Compass, Vol 3, Iss 3, Pp 205-213 (2022)
Abstract Introduction Several systemic therapies have demonstrated a survival advantage in metastatic castration resistant prostate cancer (mCRPC). Access to these medications varies significantly worldwide. In Australia until recently, patients must
Externí odkaz:
https://doaj.org/article/dc78be7e4b24417987370623f12358ff
Autor:
Amy M Dennett, Katherine E Harding, Casey L Peiris, Nora Shields, Christian Barton, Lauren Lynch, Phillip Parente, David Lim, Nicholas F Taylor
Publikováno v:
JMIR Research Protocols, Vol 11, Iss 7, p e38553 (2022)
BackgroundAccess to rehabilitation to support cancer survivors to exercise is poor. Group exercise–based rehabilitation may be delivered remotely, but no trials have currently evaluated their efficacy. ObjectiveWe aimed to evaluate the efficacy of
Externí odkaz:
https://doaj.org/article/a7a19e4fe0234d36ba4cda26689bc462
Autor:
Patricia M. Livingston, Leila Heckel, Liliana Orellana, David Ashley, Anna Ugalde, Mari Botti, Graham Pitson, Anne Woollett, Suzanne K. Chambers, Phillip Parente, Jacqueline Chirgwin, Cathrine Mihalopoulos, Barbara Lavelle, Jennifer Sutton, Jo Phipps‐Nelson, Mei Krishnasamy, Katherine Simons, Natalie Heynsbergh, Nilmini Wickramasinghe, Vicki White
Publikováno v:
Cancer Medicine, Vol 9, Iss 2, Pp 507-516 (2020)
Abstract Background Smartphone technology represents an opportunity to deliver practical solutions for people affected by cancer at a scale that was previously unimaginable, such as information, appointment monitoring, and improved access to cancer s
Externí odkaz:
https://doaj.org/article/f3cc246d86794840b927835d12a2cec2
Autor:
Amy Dennett, Katherine E Harding, Jacoba Reimert, Rebecca Morris, Phillip Parente, Nicholas F Taylor
Publikováno v:
JMIR Cancer, Vol 7, Iss 4, p e33130 (2021)
BackgroundAccess to exercise for cancer survivors is poor despite global recognition of its benefits. Telerehabilitation may overcome barriers to exercise for cancer survivors but is not routinely offered. ObjectiveFollowing the rapid implementation
Externí odkaz:
https://doaj.org/article/7b2751ce98704ae8b959891c4974a836
Autor:
Wee Kheng Soo, PhD, Madeleine King, ProfPhD, Alun Pope, PhD, Christopher Steer, MBBS, Bianca Devitt, PhD, Susan Chua, MBBS, Phillip Parente, MBBS, Ian D Davis, ProfPhD, Pēteris Dārziņš, ProfPhD
Publikováno v:
The Lancet. Healthy Longevity, Vol 2, Iss 1, Pp e24-e33 (2021)
Summary: Background: Functional assessment of patients with cancer can be challenging and is often undertaken by the clinician with minimal direct input from the patient. We developed and aimed to validate the Elderly Functional Index (ELFI), a compo
Externí odkaz:
https://doaj.org/article/80c6fa8279d04e8899479854abdc5ca3
Autor:
Dae Ho Lee, Hiroshi Isobe, Hubert Wirtz, Sabina Bandeira Aleixo, Phillip Parente, Filippo de Marinis, Min Huang, Ashwini Arunachalam, Smita Kothari, Xiting Cao, Nello Donnini, Ann-Marie Woodgate, Javier de Castro
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-16 (2018)
Abstract Background Data are scarce regarding real-world health care resource use (HCRU) for non-small cell lung cancer (NSCLC). An understanding of current clinical practices and HCRU is needed to provide a benchmark for rapidly evolving NSCLC manag
Externí odkaz:
https://doaj.org/article/4cae8ec880f24169927daef910b60e38
Autor:
Tiantian Zheng, Pan Du, Caitlin Bennett, Jianjun Yu, Heidi Fettke, Carmel Pezaro, Lavinia Spain, Chao Dai, Gargi Kothari, Shidong Jia, Linda Garrett, Ben Tran, Deborah Chang, M. Shaw, Elizabeth Liow, Angelyn Anton, Arun Azad, Chun L. Gan, Edmond M. Kwan, Shankar Siva, Claire Abou-Seif, Phillip Parente
Publikováno v:
European Urology. 81:253-262
Background Immune checkpoint inhibitor monotherapy in metastatic castration-resistant prostate cancer (mCRPC) has produced modest results. High-dose radiotherapy may be synergistic with checkpoint inhibitors. Objective To evaluate the efficacy and sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7276a39499097ca7d3fa51a317bbee53
https://doi.org/10.1016/j.eururo.2021.08.011
https://doi.org/10.1016/j.eururo.2021.08.011
Autor:
Stefano Mangiola, Jeremy Grummet, Michael Kerger, Paul Ruljancich, Ryan Stuchbery, David Clarke, Justin S. Peters, Andrew Ryan, Niall M. Corcoran, Phillip Parente, Nicholas Howard, Christopher M. Hovens, Natalie Kurganovs, Sam Norden, Anthony J. Costello, Anne Ngyuen, Corrina A Grima, Patrick McCoy, Geoff Macintyre, Philip Dundee, Marek Cmero, Ken Chow
Publikováno v:
JCO Precision Oncology
PURPOSE Androgen receptor (AR) signaling is important in prostate cancer progression, and therapies that target this pathway have been the mainstay of treatment for advanced disease for over 70 years. Tumors eventually progress despite castration thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35d4ca5a9d06303cedc1116054e14a1b
https://doi.org/10.1200/po.20.00337
https://doi.org/10.1200/po.20.00337
Autor:
Marie C Semira, Francis Parnis, Angelyn Anton, Peter Gibbs, Arun Azad, Javier Torres, Lavinia Spain, Ashray Gunjur, Andrew Weickhardt, Phillip Parente, Jeffrey C. Goh, Edmond M. Kwan, Shirley Wong, Ben Tran, Carmel Pezaro, J. Shapiro
Publikováno v:
European Journal of Cancer. 157:485-492
INTRODUCTION: Bone metastases occur frequently in castration-resistant prostate cancer (CRPC) and may lead to skeletal-related events (SREs), including symptomatic skeletal events (SSEs). Bone-modifying agents (BMAs) delay SREs and SSEs. However, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48735be8f04bf170810b1f8f2f06b2ad
https://doi.org/10.1016/j.ejca.2021.06.005
https://doi.org/10.1016/j.ejca.2021.06.005